Past-year and daily cannabis use among adults aged 19-30 are at the highest levels ever recorded by the National Institutes of Health, according to the 2022 Monitoring the Future survey.
NIH Survey Finds Cannabis Use Among Adults Highest Ever Recorded by Agency
Full story continued below.
Advertisement
The National Institutes of Health (NIH) 2022 Monitoring the Future survey found past-year and daily cannabis use among adults 19-30 years old are at the highest levels ever recorded by the agency. The survey found 44% of the cohort consumed cannabis in the past year, while 11% consumed cannabis daily.
Comparatively, past-year cannabis use among 19- to 30-year-olds was 35% in 2017 and 28% in 2012, while daily cannabis use among the cohort was 8% in 2017 and 6% in 2012.
Reports of past-year cannabis use among adults aged 35 to 50 also reached an all-time high of 28% in 2022; an increase from 25% in 2021, 17% in 2017, and 12% in 2012.
Past-year cannabis vaping was reported by 21% of adults 19 to 30 years old in 2022, the highest levels found in the survey since the question was first added in 2017 (12%). In 2021, that figure was 19% and 12% in 2017. Past-year nicotine vaping among the younger adult group also reached a historic high of 24% in 2022, nearly double the rate (14%) reported in 2017, when the NIH first added the question to the survey.
Among adults aged 35 to 50, reports of past-year cannabis vaping remained at similar levels (9% in 2022) since 2019, when these questions were first available in this age group. Prevalence of past-year nicotine vaping has also remained steady in this age group since it has been reported, with 7% reporting in 2022.
The survey found that, among adults aged 19 to 30, 8% reported past-year use of hallucinogens. Five years ago, the share was 5%, and in 2012 the share was 3%. Types of hallucinogens reported by participants included LSD, MDMA, mescaline, peyote, psilocybin mushrooms, and PCP. Most of past-year use in 2022 reported by adults in this age group involved hallucinogens other than LSD (7% in 2022).
Past-year hallucinogen use reached historically high prevalence among adults 35 to 50 years old, reported by 4% in 2022. In 2021, the share was 2%, and five and 10 years ago the share was no greater than 1%.
Over the past decade, the survey has found rates of alcohol use – including past-month use, daily drinking, and binge drinking – declined for adults 19 to 30 years old; however, past-year drinking slightly increased for this age group in 2022 (84%) compared to five years ago (82% in 2017).
The survey also found that alcohol use among adults aged 35 to 50 has shown a gradual increase over the past 10 years, with past-year drinking increasing from 83% in 2012 to 85% in 2022. Binge drinking in this older group reached its highest levels (29% in 2022), and increased over the past year, five years, and 10 years (26% in 2021; 25% in 2017; 23% in 2012).
The study also suggests that past-year use of cigarettes, sedatives, and non-medical use of opioid medications showed a 10-year decline for both adult age groups and reported past-year amphetamine use continued a 10-year decrease among 19- to 30-year-olds and a 10-year increase among 35- to 50-year-olds.
Get daily news insights in your inbox. Subscribe
End